These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 354838

  • 1. Hemodynamic effects of dopamine in patients with resistant congestive heart failure.
    Durairaj SK, Haywood LJ.
    Clin Pharmacol Ther; 1978 Aug; 24(2):175-85. PubMed ID: 354838
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A, Mussini A, Bramucci E.
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [Abstract] [Full Text] [Related]

  • 6. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V, Neuzner J, Opper H, Thormann J, Schlepper M.
    Z Kardiol; 1994 Feb; 83 Suppl 2():37-48. PubMed ID: 8091823
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dose-related hemodynamic and renal effects of dopamine in congestive heart failure.
    Beregovich J, Bianchi C, Rubler S, Lomnitz E, Cagin N, Levitt B.
    Am Heart J; 1974 May; 87(5):550-7. PubMed ID: 4818699
    [No Abstract] [Full Text] [Related]

  • 9. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R, Pucciarelli G, Nocerino L, Cocozza M, Setaro A, Torre G, Imperatore F.
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Hemodynamic effects of one administration of l-dopa in patients with left ventricular heart failure (introductory remarks)].
    Leszek P, Zieliński T, Korewicki J.
    Kardiol Pol; 1993 May; 38(5):335-9. PubMed ID: 8366641
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Isosorbide dinitrate in acute and chronic heart failure.
    Venkataraman K, Durairaj SK, de Guzman M, Haywood LJ.
    Clin Pharmacol Ther; 1979 Jan; 25(1):43-50. PubMed ID: 758242
    [Abstract] [Full Text] [Related]

  • 17. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Saborowski F, Peters P, Schneider M.
    Z Kardiol; 1991 Jan; 80 Suppl 4():63-7. PubMed ID: 1833900
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
    Stambler BS, Gottlieb SS, Singh BN, Ramanathan KB, Ogilby JD, Ellenbogen KA.
    J Am Coll Cardiol; 1995 Dec; 26(7):1679-84. PubMed ID: 7594103
    [Abstract] [Full Text] [Related]

  • 20. Hemodynamic effects of smoking in congestive heart failure.
    Nicolozakes AW, Binkley PF, Leier CV.
    Am J Med Sci; 1988 Dec; 296(6):377-80. PubMed ID: 3213837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.